Le Lézard4h
LUXTURNA Continues to Lead in Retinal Gene Therapy with Increased Market Penetration | DelveInsight
DelveInsight's "LUXTURNA Market Size, Forecast, and Market Insight Report" highlights the details around LUXTURNA, a one-time gene therapy for the treatment of patients with vision loss due to a ...
Nanoscope Announces Publication of Clinical Data on Vision Restoration in Retinitis Pigmentosa
Researchers with Nanoscope Therapeutics Inc., a biotechnology company committed to restoring vision in blind patients in real ...
Loretta Ramos Named Senior Director Of Blumhouse & K Period Media’s Screamwriting Fellowship Program
EXCLUSIVE: Loretta Ramos has been named Senior Director of Blumhouse and K Period Media’s Screamwriting Fellowship program.
David Kramer Elevated To UTA CEO; Jeremy Zimmer To Remain On Board Of Directors & Will Help Transition Before Moving On
Jeremy Zimmer is passing the leadership torch to United Talent Agency president David Kramer, who will become CEO on June 1.
Medera Completes Patient Dosing in Phase 1/2a MUSIC-HFrEF Trial of SRD-001 Gene Therapy for Heart Failure with Reduced Ejection Fraction
Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates via ...
B and T15d
‘Not Just Slapping Logos & Scooping Revenue’: Network 10’s Grand Prix Coverage Gears Up To Deliver Big Moments & Even Bigger Brand Impact
The countdown is on for the Formula 1 Louis Vuitton Australian Grand Prix 2025, and Network 10 is gearing up to deliver ... “It’s not just about slapping logos or scooping the pool of revenue ...
Finanznachrichten16d
4D Molecular Therapeutics, Inc.: 4DMT Announces First Patients Enrolled in 4FRONT-1 Phase 3 Clinical Trial Evaluating 4D-150 in Wet AMD
EMERYVILLE, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...
Business Insider16d
4DMT Announces First Patients Enrolled in 4FRONT-1 Phase 3 Clinical Trial Evaluating 4D-150 in Wet AMD
EMERYVILLE, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...
Manila Bulletin16d
Windows 10 phase out – What can you do?
For nearly 10 years now, Windows 10 has been running millions of PCs, including those of Filipinos who use it for work, school, and daily entertainment. But come October 2025, Microsoft will end ...
daxstreet20d
10 Most Iconic Car Logos and Their Hidden Meanings Explained
Car logos are more than just decorative emblems; they carry deep meanings, historical significance, and brand philosophies. While many people can recognize these logos at a glance, few understand the ...
heise online20d
Digital vehicle registration document: Germany-wide pilot phase starts in April
The pilot phase for the digital vehicle registration document starts in April. The first users will then be able to test the associated app. The pilot phase for the digital vehicle registration ...
The Washington Post22d
These are the top coronavirus vaccines to watch
As companies launched small Phase 1 trials intended to establish ... One concern is that people can develop immunity to the viral vector, making this approach potentially less useful if booster ...